| April D Sorrel, MD | |
|
295 Indest Street, New Iberia, LA 70563 | |
| (337) 365-0268 | |
| (337) 369-6922 |
| Full Name | April D Sorrel |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 295 Indest Street, New Iberia, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164770418 | NPI | - | NPPES |
| 2344196 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD206487 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| April D Sorrel, MD 295 Indest Street, New Iberia, LA 70563 Ph: (337) 365-0268 | April D Sorrel, MD 295 Indest Street, New Iberia, LA 70563 Ph: (337) 365-0268 |
News Archive
A newly available DNA-based prenatal blood test that can identify a pregnancy with Down syndrome can also identify two additional chromosome abnormalities: trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome). The test for all three defects can be offered as early as 10 weeks of pregnancy to women who have been identified as being at high risk for these abnormalities.
House Speaker John Boehner, R-Ohio, said this plan is still under discussion. Meanwhile, as the House considers this Continuing Resolution, which would provide current year funding for the federal government, it will do so under new rules for debate.
Subsolid nodules can be considered a biomarker of lung cancer risk and should be managed with long-term active surveillance.
Raising the age of eligibility and reforming some Medicare practices can go a long way to making it sustainable, according to three Arizona State University healthcare policy experts.
A meta-analysis of four randomized Phase III placebo-controlled trials confirms that the injectable drug Efalizumab, a humanized therapeutic antibody designed to selectively and reversibly block the activation, reactivation and trafficking of T-cells that lead to the development of psoriasis, had an acceptable safety and efficacy profile in the treatment of psoriasis in heavy patients, researchers at Mount Sinai School of Medicine announced today.
› Verified 9 days ago
Dr. Walter Inman Scott Iii, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2308 E Main St, Suite G, New Iberia, LA 70560 Phone: 337-367-2001 Fax: 337-365-3050 | |
Jill G Brown, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 520 N Lewis St, Ste 202, New Iberia, LA 70563 Phone: 337-367-2001 Fax: 337-365-3050 | |
Tomas Golan, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 2308 E Main St, New Iberia, LA 70560 Phone: 337-560-5005 Fax: 337-560-9757 | |
Dr. Henry D Eikel, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 520 N Lewis St, Suite 202, New Iberia, LA 70563 Phone: 337-367-2001 Fax: 337-365-3050 | |
Allison Z Rader, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 295 Indest St, New Iberia, LA 70563 Phone: 337-365-0268 Fax: 337-369-6922 | |
Dr. Karunasri Janga, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2308 E Main St Ste G, New Iberia, LA 70560 Phone: 337-367-2001 Fax: 337-365-3050 |